BE-23372M, a novel protein tyrosine kinase inhibitor, was isolated from the culture broth of a fungus. The producing strain, F23372, was identified as Rhizoctonia solani, based on the cultural and morphological characteristics. The active principle was extracted from the myceliumwith acetone and purified by solvent extraction, silica gel column chromatography and Sephadex LH-20 column chromatography.
BE-23372M, a novel protein tyrosine kinase inhibitor, was isolated from the culture broth of a fungus. The producing strain, F23372, was identified as Rhizoctonia solani, based on the cultural and morphological characteristics. The active principle was extracted from the myceliumwith acetone and purified by solvent extraction, silica gel column chromatography and Sephadex LH-20 column chromatography.
BE-23372Mshowed strong inhibitory activity against EGF receptor kinase with IC50 values of 0.02 and 0.03/im on two different substrates, whereas IC50 values against protein kinase C and CAMP-dependent protein kinase were 4.5 and >20 /jM, respectively. The compound inhibited the growth of A431 human epidermoid carcinoma and MKN-7human stomach cancer cell lines with IC50 values of 8 and 24/xm, respectively.
Manyligand-activated growth factor receptors and a number of oncogene products are protein tyrosine kinases1*. Their aberrant activation has been implicated in humanclinical cancers2). Translocation of the abl gene was found in chronic myelogeneous leukemia3). Amplification of the EGFreceptor gene is often found in squamous cell carcinoma4). Amplification of its homolog, erbB-2, has been detected in breast, ovary and stomach adenocarcinoma5>6). Expression of erbB-2 protein has been known to be an indicator of a poor prognosis in these cancers6~9). Activation of other protein tyrosine kinases such as metlo\ k-samxl) and so on in some humancancers has also been reported.
A specific inhibitor for a certain enzyme is generally valuable for its further study. For some protein tyrosine kinases found in human cancers, an inhibitor would be a useful tool to study the relationships between kinase activity and cancer cell proliferation. The growth inhibitory effects of some EGFreceptor kinase inhibitors on cultured cell lines12~14) suggested that the screening for protein tyrosine kinase inhibitors may lead to new, selective drugs for treating cancer.
From this point of view, we have screened protein tyrosine kinase inhibitors of microbial origin, using EGFreceptor kinase and found a novel inhibitor, BE-23372M.In this publication, we describe the producing organism, fermentation, isolation and biological activities of BE-23372M. The physico-chemical properties, structure elucidation and synthetic studies of this compoundwill be reported in the following papers1 5' 1 6).
Materials and Methods

Microorganism
The producing organism, strain F23372, was isolated from the bark of Ginkgo bioba L. collected in MAR. 1994 AgeoCity, Saitama Prefecture, Japan. This strain has been deposited in the National Institute of Bioscience and Human-Technology (formerly the Fermentation Research Institute), Agency of Industrial Science and Technology, Japan, under the accession No. FERMP-12077.
Fermentation
The culture F23372 from an agar slant was inoculated into four 500-ml conical flasks each containing 100ml of the following seed medium (pH 6.0): Polypepton 0.3%, glucose 1%, wheat germ 1%, gluten meal 0.5%, meat extract 0.3%, maltose 3%, NaCl 0.2%, NaNO3 0.1%, KH2PO4 0.1%, MgSO4-7H2O
0.00004%, ZnSO4-7H2O 0.00008%, Na2B4O7-10H2O 0.00008% and (NH4)6Mo7O24-4H2O 0.00024%.
These flasks were then incubated on a rotary shaker (180rpm) at 28°C for 72 hours. The seed culture (2ml each) was transferred into 145 flasks of the same type containing 100 ml of the above mediumand incubated on a rotary shaker (180rpm) at 28°C for 72 hours.
Protein Kinase Assays
EGFreceptor was partially purified from A431 cells by means of WGA agarose column chromatography as described by Akiyama et al.17) . The enzyme assay was performed in 50 /il of reaction mixture containing 1 /iunit (l~2/xg protein) EGF receptor kinase, 20mMHEPES Na (pH 7.4), 30mM MgCl2, 0.5 mMMnCl2, 150 mMNaCl, 1 //g/ml recombinant human EGF (Wakunaga Pharmaceutical Co., Osaka, Japan), 20fm [y-32P]ATP (9.25 kBq/assay, Amersham), 0.1% Triton X100, 10% glycerol, 1 mg/ml poly(Glu : Tyr) 4 : 1 (Sigma) and the test compound. The mixture was incubated at 30°C for 30 minutes. The reaction was terminated with 10 /d of 70% trichloroacetic acid, and radioactivity incorporated into the acid precitable fraction was collected on Multiscreen HAfilter (Millipore) and counted by a liquid scintillation counter. When RR-SRCpeptide (Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly, 1 mg/ml, Peptide Institute Inc., Osaka, Japan) was used as a substrate, the reaction was terminated with 25fA of 10% trichloroacetic acid, and the radioactivity incorporated was determined using P81 paper (Whatman) as described by Glass et al.18) . Crude lysate containing protein kinase C was prepared from mouse brains, and the kinase activity was determined as described by Kikkawa et al. 1 9\ CAMP-dependentprotein kinase was assayed as described previously20).
Cell Culture and Proliferation Assay A431humanepidermoid carcinoma cells were cultured in Dulbecco's modified Eagle's medium (DMEM)supplemented with 10% fetal calf serum (FCS), and MKN-7human stomach cancer cells were grown in RPMI1640 supplemented with 10% FCS. Both cell lines were maintained at 37°C in a humidified 5% CO2 atmosphere. Cells were seeded into 96-well microtiter plates (2 x 103 cells/well) and incubated for 24 hours. The test sample, dissolved in dimethyl sulfoxide, was added in serial dilutions. After addition, the plates were incubated for 72 hours. Cells were fixed with 50% trichloroacetic acid and stained with 0.4% sulforodamine B. The dye was extracted from the stained cells with lO mMtris(hydroxymethyl)aminomethane solution. The absorbance of the extract was measured at 540nm.IC50 value was calculated from the absorbance in the presence and absence of the inhibitor.
Results
Description of Producing Organism Strain F23372 was characterized by the fast-growing mycelium covering 90 mmpetri plates of 5 media at 28°C in 3 days (Table 1) .
Neither sexual spores nor asexual spores were observed on the media used, while the scleotia were seen on potato -dextrose agar medium. The scleotia were black or brown and irregular in shape and size. Hyphae were light to dark brown and stout, 7.2~8.5fim in diameter. Side branches originated in the distal part of the cell, were constricted at the point of origin and had septa formed close to the hypha.
Glamp-connections were not seen (Fig. 1 ). The nuclear staining revealed that the strain is multinucleate. Fig. 1 . Photomicrograph of hyphae of strain F23372.
The inserted scale is 10/mi. Based on these cultural and morphological characteristics, strain F23372 was identified as Rhizoctonia solani (Agonomycetes)2 1).
Isolation
After heating at 90°C for 10 minutes, the culture broth (ca. 14 liters), was premixed with Celite and filtered. The mycelial cake obtained was dispersed and soaked in 12 liters of acetone, and the mixture was stirred at room temperature for 1 hour. After filtering, the acetone extract was concentrated to about 1.8 liters, which was adjusted to pH 3 with 1 n HC1and extracted twice with ethyl acetate (each 1.8 liters). The ethyl acetate extract was combined and concentrated to dryness.
The residue obtained was dissolved in chloroform and applied to silica gel column (15 g, Kieselgel 60, Merck), which was washed with chloroform and then eluted with a mixture of chloroform -methanolformic acid (100 : 10 : 1). The active fractions were collected and evaporated to dryness. The residue was dissolved in a mixture of chroloform-methanol-ethanol-water (5 :2:2: 1) and applied to a column of Sephadex LH-20 (2.5 i.d. x 50 cm, Pharmacia), and then developed with the same solvent mixture mentioned above. The active fractions were concentrated and applied to Sephadex LH-20 column chromatography again. The active fractions thus obtained were concentrated to give 5.7mg of BE-23372Min the form of a reddish orange solid substance.
Biological Activities
To study the selectivity of BE-23372M, the inhibitory activity against protein kinase C and CAMP-dependent protein kinase together with EGFreceptor kinase was examined. BE-23372Mexhibited the strongest inhibitory activity against EGFreceptor kinase with IC50 values 0.02^m for poly(Glu : Tyr) 4 : 1 substrate, and 0.03 fiM for RR^RCsubstrate. On the other hand, IC50 values against protein kinase C and CAMP-dependent protein kinase were 4.5/iM and >20fiu, respectively (Table 2 ). These results indicate that BE-23372Mis a potent and selective inhibitor of EGFreceptor kinase. MAR. 1994 The effect of BE-23372Mon the cell proliferation was examined, using two human cancer cell lines A431 and MKN-7. A431 cells are known to have overexpressed EGFreceptor28), and MKN-7cells are reported to be expressing erb-B229\ BE-23372M showed growth inhibitory activities against both cell lines. IC50 values against A431 and MKN-7were 8 //M and 24jam, respectively. Discussion Intracellular signalling pathways mediating the effect of growth factors and oncogenes on cell proliferation and transformation present a challenging new class of target sites for anticancer drug development. These pathways include GTP-binding proteins, protein tyrosine kinases, protein serine/threonine kinases, nuclear transcription factors and so on. Amongthem, protein tyrosine kinases are the most extensively studied, and mucheffort is being given to the search for protein tyrosine kinase inhibitors.
Genistein, isolated from Pseudomonas sp., was competitive inhibitor of the binding of ATPto protein tyrosine kinases22'23). Erbstatin was isolated from Streptomyces sp. as a potent EGFreceptor kinase inhibitor, and blocked the peptide site of EGF receptor12'240. Lavendustin A, isolated from Streptomyces griseolavendus, was one of the most potent EGFreceptor kinase inhibitors25). Beside naturally occurring inhibitors, some synthetic compounds are developed as EGFreceptor protein kinase inhibitors13'14'26'27*.
BE-23372M,isolated from Rhizoctonia solani F23372, is a new member of these protein tyrosine kinase inhibitors.
BE-23372M was a potent inhibitor of EGF receptor kinase (IC50 0.02 -0.03 /zm). The compound did not block the binding of EGFto its receptor (data not shown). The selectivity of this compound for the inhibition of EGF receptor kinase compared with protein kinase C and CAMP-dependent protein kinase was more than 150-fold (Table 2) . Thus, the compound has been proved as a potent and selective inhibitor of EGFreceptor kinase. The effects of BE-23372Mon the other protein tyrosine kinases and on EGF receptor autophosphorylation in addition to the kinetic studies will be described elsewhere30).
